OraSure Technologies stock trades above USD 3.00 consensus target
Published on 10/15/2026 at 21:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSConsensus target and next report
- MarketBeat lists a USD 3.00 consensus target for OraSure Technologies on October 15, 2026.
- Second-quarter revenue reached USD 30.64 million, while GAAP gross margin was 43.50 percent.
- OraSure Technologies stock costs EUR 3.39 at 9:15 p.m. CEST at Lang & Schwarz on October 15, 2026, up 2.96 percent on Nasdaq.
- The next quarterly report is expected on November 4, 2026.
OraSure Technologies stock trades above a USD 3.00 consensus target on October 15, 2026, while the target sits 21.47 percent below the USD 3.82 Nasdaq quote at 3:23 p.m. ET. The consensus includes two Hold ratings and one Sell rating, according to MarketBeat on October 15, 2026. OraSure Technologies stock was trading at EUR 3.39 at Lang & Schwarz on October 15, 2026 at 9:15 p.m. CEST, up 2.96 percent on Nasdaq.
Second-quarter margins improved
The latest reported quarter showed a sharper operating improvement than the revenue line alone suggests. OraSure reported USD 30.64 million in second-quarter 2026 revenue, while GAAP gross margin reached 43.50 percent, up from 42.30 percent in the first quarter. The figures and the company outlook were discussed in the second-quarter call transcript carried by Yahoo Finance on August 5, 2026.
Price position and yearly range
The USD 3.82 Nasdaq quote stood between the 52-week low of USD 2.08 and high of USD 4.58 on October 15, 2026. That places the stock 16.59 percent below its yearly high. OraSure develops rapid diagnostic tests and specimen collection products, including its OraQuick portfolio, according to the company investor page at OraSure Technologies.
Valuation and next report
Market capitalization stood at USD 263.5 million on October 15, 2026, and the trailing P/E ratio was minus 5.53. The next quarterly report is expected on November 4, 2026, after the market close, with consensus revenue of USD 31.14 million and consensus earnings per share of minus USD 0.18, according to MarketBeat.
Comparison with peers
OraSure Technologies: plus 2.96 percent, P/E minus 5.53, market capitalization USD 263.5 million
Becton, Dickinson and Company (NYSE, USD): plus 2.63 percent, P/E 58.41, market capitalization USD 52.8 billion
Quest Diagnostics Incorporated (NYSE, USD): plus 2.03 percent, P/E 25.28, market capitalization USD 26.3 billion
Price and investor context
The market picture combines a positive Nasdaq session with a cautious consensus target and a reporting date less than three weeks away. The valuation remains tied to the company converting higher margins and new diagnostic launches into sustained revenue growth.
The stock was trading at EUR 3.39 at Lang & Schwarz on October 15, 2026 at 9:15 p.m. CEST, up 2.96 percent on Nasdaq. The further course of trading is shown by the continuously updated real-time quote of OraSure Technologies stock.
OraSure Technologies market data
- Company: OraSure Technologies, Inc.
- ISIN: US68554V1089
- Ticker: OSUR
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 15, 2026, 9:15 p.m. CEST): EUR 3.39
- Change on Nasdaq: plus 2.96 percent
- Market capitalization: USD 263.5 million (as of October 15, 2026)
- 52-week range: USD 2.08-USD 4.58 (as of October 15, 2026)
- Sector / Industry: Health care / Diagnostics
- Next earnings date: November 4, 2026, estimated
Market context: Market report S&P 500.
